"After 30 years of R&D, the biotechnology industry has matured. The next challenges are large-scale production of biological products. Germany's research institutions and private industry have been among the first to make the leap to the unique R&D and manufacturing methodologies that biotechnology requires. This panel discussion will present key facts about the biomanufacturing industry and capacity in Germany; the latest research on bioengineering and large-scale production processes; the role of CMOs in addressing the burgeoning worldwide product pipeline; and the particular challenges of clinical-scale biomanufacturing."

Objective1:"Provide an overview of the challenges of large-scale and clinical-scale production and practical solutions to
tomorrow's manufacturing needs."

Objective2:Present information about cutting-edge research in the field of bioengineering and manufacturing technologies.

Objective3:Address a panel of top industry executives in a moderated Q&A session.